SWISF - New to The Street TV Features Five Corporate Guest Interviews Episode 537 Airs on the FOX Business Network Monday December 11 2023 at 10:30 PM PT | Benzinga
NEW YORK, Dec. 08, 2023 (GLOBE NEWSWIRE) -- FMW Media's New to The Street, a nationally televised business show, announces episode 537, airing on the FOX Business Network on Monday, December 11, 2023, at 10:30 PM PT.
New to The Street's 537th episode features the following five (5) corporate interviews:
1). InsurTech Company - Reliance Global Group, Inc.'s (NASDAQ:RELI) (NASDAQ:RELIW) () interview Rick Emg, Chief Operating Officer of Subsidiaries, and Grant Barra, Senior Vice-President Operations.
2). Women's Healthcare – Aspira Women's Health (NASDAQ:AWH) () interview with Nicole Sandford, President, CEO, and Board Member, Michell Snider, Senior Vice-President of Commercial Strategy and Operations, and Lottie Wilder, Market Development Manager
3). Biopharmaceutical -Acurx Pharmaceuticals, Inc.'s (NASDAQ:ACXP) () interview with David Luci, President/CEO.
4). New Blockchain Segment - "The Business of Blockchain," with TV Host Jane King; "Microlending on the Blockchain" topic sponsored by Verda Ventures; interviews with Jia's Zack Mark, CEO/Co-Founder, Huma Finance's ("Huma") Jaou Toure, Head of Business & Operations, and Verda Ventures' Alex Witt, General Partner.
5). "Sekur Privacy & Sekur Security – Weekly Hack" segment with internet privacy expert Mr. Alain Ghiai, CEO, Sekur Private Data, Ltd. (OTCQB:SWISF) (CSE:SKUR) (FRA: GDT0) (Sekur®).
Episode 537
Reliance Global Group, Inc.'s (NASDAQ:RELI) (NASDAQ:RELIW) () Rick Emg, Chief Operating Officer of Subsidiaries, and Grant Barra, Senior Vice-President Operations are at Nasdaq MarketSite Studio with New to The Street's TV Host Jane King talking about the Company. RELI is an InsurTech Company transforming the insurance agency industry using AI and cloud computing technologies. Grant provides a corporate overview and talks about organic growth as the Company consolidates all its subsidiaries as "OneFirm." Throughout its operational history, RELI has acquired many significant entities, and the "OneFirm" approach brings together all Reliance Global Group's agencies while providing many synergistic opportunities. Rick talks about his 27 years of experience in the insurance industry and how he watched the takeovers of many Michigan insurance agencies and then placed them into larger organizations. What makes RELI different is that they acquire well-run agencies but allow them to maintain their successful business operations without disruptive and massive immediate changes. RELI has a central office that provides operational assistance, which allows field offices to grow. The RELI Exchange Partner Network can leverage synergies among its agencies that can lower costs, increase revenues, and provide access to other markets, insurance product offerings, and human resource talents. Grant informs that at the bottom of the Company's main page of its website, https://relianceglobalgroup.com/, viewers can opt-in to receive timely and informative updates about corporate ongoings. Customers who want insurance quotes can use RELI's 5minuteinsure.com. To learn more about RELI's Exchange Partner Network, agents can go to https://reliexchange.com/contact/. The on-screen QR code is available during the show; download or visit Reliance Global Group, Inc.- https://relianceglobalgroup.com/.
From the Nasdaq MarketSite Studio, New to The Street's TV Host Jane King interviews Nicole Sandford, President, CEO, and Board Member, Michell Snider, Senior Vice-President of Commercial Strategy and Operations, and Lottie Wilder, Market Development Manager of Aspira Women's Health (NASDAQ:AWH) (). The Company is transforming gynecologic health by discovering, developing, and commercializing innovative blood-based diagnostic test kits for women with ovarian cancer and other disorders. Nicole updates viewers that the Company completed its clinical study on its OvaWatchSM product for monitoring expansion. Management launched in 2022 the OvaWatch test kit that can monitor and manage women with ovarian adnexal masses. The test provides a single risk assessment score that delivers a negative predictive value of 99% and can advance treatment protocols based on test result outcomes. OvaWatch allows physicians to choose their patients' clinical management path confidently. Management is focusing on effective commercialization and marketing strategies, looking at a data set to see what is working and not working for AWH to make money. Nicole feels hiring qualified and talented people continues to improve the bottom-line results at AWH. Michell Snider gives her employment history with the Company and discusses a three-point growth strategy: 1) profitability, 2) core physician expansion and retention, and 3) target large-scale partnerships. Lottie Wilder is AWH's Market Development Manager and shares her personal health experiences. Her family has an ovarian cancer history and has identified that cancer gene in her family tree. With one ovary removed and the other with an adnexal mass, Lottie talks about her experience as a patient with OvaWatch. With a 99.5% personal negative predictive value, Lottie manages her health, accordingly, believing she can enter menopause naturally without removing the other ovary. Nicole sees 2024 as AWH's year to aggressively market the Company's products and build upon its proven successes. With the right team, products, and innovations, AWH continues to help women with ovarian cancer and other gynecologic disorders. The on-screen QR code is available during the show to download more info or visit Aspira Women's Health - https://aspirawh.com/.
New to The Street's TV Host Jane King from the Nasdaq MarketSite Studio talks with David Luci, the President/CEO of Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) (). As a clinical-stage biopharmaceutical business, ACXP is developing a new class of antibiotics for life-threatening bacterial infections. David updates viewers on the Company's FDA Phase 2 clinical trial on the Ibezapolstat drug, ...